Antibodies specific for CD70 and their uses

MYPI2025003778A0Undetermined Publication Date: 2019-08-01PFIZER INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025003778
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-03-12
Filing Date
2019-01-31
Publication Date
2019-08-01
Patent Text Reader

Abstract

The present invention provides antibodies that specifically bind to CD70 (Cluster of Differentiation 70). The invention further provides bispecific antibodies that bind to CD70 and another antigen (e.g., CD3). The invention further relates to antibody encoding nucleic acids, and methods of obtaining such antibodies (monospecific and bispecific). The invention further relates to therapeutic methods for use of these antibodies for the treatment of CD70-mediated pathologies, including cancer.
Need to check novelty before this filing date? Find Prior Art